Language

Venarus 450 mg + 50 mg — packaging
Packaging may differ

Venarus 450 mg + 50 mg prices in Yerevan pharmacies

diosmin, hesperidin · tablets film-coated · 450 mg + 50 mg · over the counter

ALIUM JSC · Russia

Registration No. 20160 · valid until 25 Oct 2026

  • Over the counter

Prices at 7 online pharmacies

60 pcs · by pack price · prices from pharmacy websites as of 15 Oct 2026

in stock · out of stock · no mark — the pharmacy does not report stock⁠About these prices

These are prices of the pharmacy chains' online shops, not of a particular branch. The list is sorted by pack price; pharmacies where the medicine is out of stock come last.

“≈ … per unit” is Medaro’s calculation: the pack price divided by the number of units (for liquids and ointments — per 10 ml or 10 g), rounded.

Medaro does not sell medicines and is not paid by pharmacies for their place in the list.

Medaro does not sell medicines and is not paid by pharmacies for their place in the list.

Alternatives 2

Same composition, form and strength — original medicines and generics; listed alphabetically. Switch only on the advice of a doctor or pharmacist.

Product record

Trade name
Venarus
Active ingredient (INN)
diosmin, hesperidin
ATC code
C05CA53
Registration certificate
No. 20160,
Dispensing
Over the counter

The register has no link to the official leaflet yet — read the leaflet in the pack.

State Register of Medicines (pharm.am) (opens in a new tab)
Show all detailsHide details
Dosage form
tablets film-coated
Strength
450 mg + 50 mg
Marketing authorisation holder
ALIUM JSC, No: 2, Quarter A, Obolensk working settlement, Serpukhov city, 142279, Moscow region, Russia
Manufacturer
ALIUM JSC, build. 1, No: 2, Quarter A, Obolensk working settlement, Serpukhov city district, 142279, Moscow region- quality control, batch releaser, ALIUM JSC, No: 2, Quarter A, Obolensk working settlement, Serpukhov city district, 142279, Moscow region, Russia- bulk manufacturer, packager
Country
Russia

Details from the State Register of Medicines of Armenia as of 31 Aug 2026. No indications, directions for use or dosing regimen here — read the official leaflet.

Spotted an error? Let us know

As a rule, we will send you a confirmation that your message has been received and, once the check is done, its outcome. We need your address only for emails about this message: it is not published on the site and is not added to any mailing list. Privacy policy